Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity.

Kleer CG, Oberman HA.

Am J Surg Pathol. 1998 May;22(5):569-75.

PMID:
9591727
2.
3.
4.

KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome.

Azoulay S, Laé M, Fréneaux P, Merle S, Al Ghuzlan A, Chnecker C, Rosty C, Klijanienko J, Sigal-Zafrani B, Salmon R, Fourquet A, Sastre-Garau X, Vincent-Salomon A.

Mod Pathol. 2005 Dec;18(12):1623-31.

6.

Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.

Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM.

Cancer. 2002 Apr 15;94(8):2119-27. Review.

7.

Adenoid cystic carcinoma of the breast.

Ro JY, Silva EG, Gallager HS.

Hum Pathol. 1987 Dec;18(12):1276-81. Review.

PMID:
2824330
8.

Proliferative activity and p53 expression in adenoid cystic carcinoma of the breast.

Pastolero G, Hanna W, Zbieranowski I, Kahn HJ.

Mod Pathol. 1996 Mar;9(3):215-9.

PMID:
8685217
9.

Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.

Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE.

Mod Pathol. 2003 Dec;16(12):1265-72.

10.

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.

Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG.

Cancer. 1991 Aug 1;68(3):549-57.

11.

Histologic grading of adenoid cystic carcinoma of the salivary glands.

Szanto PA, Luna MA, Tortoledo ME, White RA.

Cancer. 1984 Sep 15;54(6):1062-9.

13.

Adenoid cystic carcinoma of the breast.

Leeming R, Jenkins M, Mendelsohn G.

Arch Surg. 1992 Feb;127(2):233-5. Review.

PMID:
1311551
14.

Adenoid cystic breast carcinoma: high rates of margin positivity after breast conserving surgery.

Hodgson NC, Lytwyn A, Bacopulos S, Elavathil L.

Am J Clin Oncol. 2010 Feb;33(1):28-31. doi: 10.1097/COC.0b013e31819fdfc8.

PMID:
19730354
15.

Multicentric mammary carcinoma: evidence of monoclonal proliferation.

Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA.

Cancer. 2002 Apr 1;94(7):1910-6.

16.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
17.

Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.

Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A.

Cancer. 2003 Sep 1;98(5):1055-60.

18.

Management of adenoid cystic carcinoma of minor salivary glands.

Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D.

J Oral Maxillofac Surg. 2006 Jul;64(7):1114-20.

PMID:
16781345
19.

Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?

Mendez JE, Fey JV, Cody H, Borgen PI, Sclafani LM.

Ann Surg Oncol. 2005 Jan;12(1):24-8. Epub 2004 Dec 27.

PMID:
15827774
20.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793

Supplemental Content

Support Center